PointState Capital’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

PointState Capital’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-76,968	Closed	-$2.8M	–	178
2016 Q4	$2.8M	Sell	76,968 -2,732	-3%	-$96.7K	0.04%	105
2016 Q3	$3.04M	Buy	+79,700	New	+$1.18M	0.03%	119

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

PointState Capital's CLCD Position: Q1 2017 in Review

PointState Capital sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 76,968 shares — an estimated $2.8M sold.

PointState Capital first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $3.04M in Q3 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

PointState Capital reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
PointState Capital sold 76,968 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $2.8M.
PointState Capital first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
PointState Capital's CoLucid Pharmaceuticals, Inc. position peaked at $3.04M in Q3 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on PointState Capital's 13F filing for Q1 2017, filed 15 May 2017.